Generated: May 28, 2017
|Title:||Treatment of HIV and other viral infections using combinatorial therapy|
|Abstract:||Novel antiviral combinations for the treatment or prevention of viral infections, in particular, HIV, are disclosed. This new antiviral therapy employs either DP-178 or DP-107, viral fusion inhibitors, in combination with at least one other antiviral therapeutic agent. The combinations of the invention are better than single therapies alone, and in certain cases are synergistic. The use of DP-178 or DP-107 is an ideal therapy to combine with another antiviral, given both the novel mechanism which this therapeutic blocks HIV transmission and the non-toxicity of the therapeutic.|
|Inventor(s):||Johnson; M. Ross (Chapel Hill, NC), Lambert; Dennis Michael (Cary, NC)|
|Assignee:||Trimeris, Inc. (Durham, NC)|
Patent Claim Types:|
see list of patent claims
|Use; Dosage form; Composition;|
|PCT Filed||June 06, 1996||PCT Application Number:||PCT/US96/09499|
|PCT Publication Date:||December 19, 1996||PCT Publication Number:||WO96/40191|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0831873||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.